M. Bieniarz

发表

The financial burden of destination left ventricular assist device therapy: Who and when?

R. Delgado, M. Bieniarz, 2007, Current cardiology reports.

Serum biomarkers in severe refractory cardiogenic shock.

Nishant R. Shah, D. Mann, P. Loyalka, 2013, JACC. Heart failure.

Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.

Jessica K. Zegre‐Hemsey, A. Jacobs, T. Henry, 2021, Circulation.

Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA’s Mission: Lifeline

C. Granger, A. Jacobs, T. Henry, 2020 .

Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect.

O. Frazier, P. Loyalka, I. Gregoric, 2008, Texas Heart Institute journal.

Emergency Interhospital Transfer of Patients With ST‐Segment–Elevation Myocardial Infarction: Call 9‐1‐1—The American Heart Association Mission: Lifeline Program

A. Jacobs, W. French, M. Bieniarz, 2022, Journal of the American Heart Association.

Glycine receptor β–subunit gene mutation in spastic mouse associated with LINE–1 element insertion

S. Kingsmore, M. Caron, B. Giros, 1994, Nature Genetics.

Genetic mapping of Pp11r, a thymocyte gene expressed during apoptosis, to mouse Chromosome 15

S. Kingsmore, M. Seldin, M. Watson, 2004, Mammalian Genome.

Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates

M. Borrego, A. Spyropoulos, C. Mahan, 2012, Thrombosis and Haemostasis.

Bridge to transplantation with the TandemHeart: bending the indications in a chronic aortic dissection patient with postcardiotomy shock.

J. Coselli, S. Lemaire, O. Frazier, 2008, Texas Heart Institute journal.